Angiopoietin-1 and angiopoietin-2 as serum biomarkers for ectopic pregnancy and missed abortion. A case-control study

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 145-151

  Daponte, Alexandros ^a   Deligeoroglou, Efthimios ^b   Pournaras, Spyros ^a   Tsezou, Aspasia ^a   Garas, Antonios ^a   Anastasiadou, Foteini ^a   Hadjichristodoulou, Christos ^a   Messinis, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Abortion; Angiopoietin; Biomarker; Ectopic pregnancy

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; MESSENGER RNA;

ADULT; ANGIOPOIETIN 1 GENE; ANGIOPOIETIN 2 GENE; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ECTOPIC PREGNANCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE LOCATION; GESTATIONAL AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSED ABORTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE LEVEL; TRANSVAGINAL ECHOGRAPHY; TROPHOBLAST;

ABORTION, MISSED; ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY, ECTOPIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84868641893     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.031     Document Type: Article

References (37)

1. Kirk E., Papageorghiou A.T., Van Calster B., et al. The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location'. Hum Reprod 2009, 24:2451-2456.
2. Folkman J., Klagsbrun M. Angiogenic factors. Science 1987, 235:442-447.
3. Davis S., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169.
4. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
5. Valenzuela D.M., Griffiths J.A., Rojas J., et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A 1999, 96:1904-1909.
6. Schiessl B., Innes B.A., Bulmer J.N., et al. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 2009, 30:79-87.
7. Bolin M., Wiberg-Itzel E., Wikstrom A.K., et al. Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia. Am J Hypertens 2009, 22:891-895.
8. Seval Y., Sati L., Celik-Ozenci C., Taskin O., Demir R. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta. Placenta 2008, 29:809-815.
9. Wang Y., Tasevski V., Wallace E.M., Gallery E.D., Morris J.M. Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency. BJOG 2007, 114:1427-1431.
10. Babischkin J.S., Suresch D.L., Pepe G.J., Albrecht E.D. Differential expression of placental villous angiopoietins-1 and -2 during early, mid and late baboon pregnancy. Placenta 2007, 28:212-218.
11. Hirokoshi K., Maeshima Y., Kobayashi K., et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Am J Hypertens 2005, 18:1181-1188.
12. Kaufmann P., Mayhew T.M., Charnock-Jones D.S. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004, 25:114-126.
13. Geva E., Ginzinger D.G., Zaloudek C.J., Moore D.H., Byrne A., Jaffe R.B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002, 87:4213-4224.
14. Ong S., Lash G., Baker P.N. Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 2000, 14:969-980.
15. Dunk C., Shams M., Nijjar S., et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000, 156:2185-2199.
16. Zhou Y., Bellingard V., Feng K.T., McMaster M., Fisher S.J. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol 2003, 263:114-125.
17. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395.
18. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
19. Makrydimas G., Sotiriadis A., Savvidou M.D., Spencer K., Nicolaides K.H. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy. Prenat Diagn 2008, 28:175-179.
20. Demir R., Kayisli U.A., Cayli S., Huppertz B. Sequential steps during vasculogenesis and angiogenesis in the very early human placenta. Placenta 2006, 27:535-539.
21. Carlson T.R., Feng Y., Maisonpierre P.C., Mrksich M., Morla A.O. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 2001, 276:26516-26525.
22. Plaisier M., Rodrigues S., Willems F., Koolwijk P., van Hinsbergh V.W., Helmerhorst F.M. Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues. Fertil Steril 2007, 88:176-187.
23. Plaisier M., Dennert I., Rost E., Koolwijk P., van Hinsbergh V.W., Helmerhorst F.M. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions. Hum Reprod 2009, 24:185-197.
24. Zhang E.G., Smith S.K., Baker P.N., Charnock-Jones D.S. The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae. Mol Med 2001, 7:624-635.
25. Greenwold N., Jauniaux E., Gulbis B., Hempstock J., Gervy C., Burton G.J. Relationship among maternal serum endocrinology, placental karyotype, and intervillous circulation in early pregnancy failure. Fertil Steril 2003, 79:1373-1379.
26. Jauniaux E., Burton G.J. Pathophysiology of histological changes in early pregnancy loss. Placenta 2005, 26:114-123.
27. Kingdom J.C., Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997, 18:613-621. [discussion 623-616].
28. Burton G.J., Jauniaux E., Watson A.L. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol 1999, 181:718-724.
29. Sharkey A.M., Day K., McPherson A., et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 2000, 85:402-409.
30. Asahara T., Chen D., Takahashi T., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998, 83:233-240.
31. Geva E., Jaffe R.B. Role of angiopoietins in reproductive tract angiogenesis. Obstet Gynecol Surv 2000, 55:511-519.
32. Vuorela P., Carpen O., Tulppala M., Halmesmaki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 2000, 6:276-282.
33. Daponte A., Pournaras S., Zintzaras E., et al. The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy. Hum Reprod 2005, 20:3163-3166.
34. Horne A.W., Shaw J.L., Murdoch A., et al. Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy. J Clin Endocrinol Metab 2011, 96:E104-E108.
35. Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004, 25:103-113.
36. Gotsch F., Romero R., Kusanovic J.P., et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med 2008, 21:389-402.
37. Roviezzo F., Tsigkos S., Kotanidou A., et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005, 314:738-744.